Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal fluticasone furoate to prevent chronic rhinosinusitis in nasopharyngeal carcinoma patients
TCTR20210203001Phase 2Recruiting
- Sponsor
- Mahidol University
- Start
- Dec 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluticasone in chronic rhinosinusitis (CRS), sponsored by Mahidol University. Started Dec 2015; status: recruiting.
02
Drugs
fluticasone
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on TCTR20210203001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210203001.